Neoadjuvant Treatment for Advanced Rectal Carcinoma
NCT02551237
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
103
Enrollment
OTHER
Sponsor class
Conditions
Rectal Carcinoma
Interventions
RADIATION:
50 Gy
DRUG:
Capecitabine
RADIATION:
25 Gy
Sponsor
UNICANCER